The article discusses Jim Cramer's views on Moderna, Inc. (NASDAQ:MRNA) and its position among the stocks he talks about. Despite acknowledging potential value in Moderna, Cramer has been cautious about the stock. The company focuses on mRNA technology for vaccines and treatments.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing